Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (611-620 of 681) with videos related to

Pageof 69
Sort By:
The New England Journal of Medicine|October 16, 2009
Interleukin-2 therapy in patients with HIV infection, , D Abrams, et al.
Circulation|June 21, 2008
State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summarySteven K Grinspoon, Carl Grunfeld, Donald P Kotler, et al.
Lancet (London, England)|August 22, 2015
The Vancouver Consensus: antiretroviral medicines, medical evidence, and political willChris Beyrer, Deborah L Birx, Linda-Gail Bekker, et al.
Trials|October 21, 2020
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis planPradeesh Sivapalan, Charlotte Suppli Ulrik, Therese Sophie Lappere, et al.
Annals of Internal Medicine|March 15, 2021
Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort StudyFrédérique Chammartin, Sara Lodi, Roger Logan, et al.
HIV Medicine|October 7, 2017
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimensA Cozzi-Lepri, R Zangerle, L Machala, et al.
Plos One|January 24, 2013
Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study)Ann K Sullivan, Dorthe Raben, Joanne Reekie, et al.
Plos One|December 31, 2015
Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin AmericaAnne Marie W Efsen, Anna Schultze, Frank A Post, et al.
HIV Medicine|May 12, 2015
Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across EuropeM Mansfeld, A Skrahina, L Shepherd, et al.
The Lancet. HIV|March 5, 2016
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort studyDaria N Podlekareva, Anne Marie W Efsen, Anna Schultze, et al.
Pageof 69

Showing results (611-620 of 681) with videos related to

Sort By:
Pageof 69
The New England Journal of Medicine|October 16, 2009
Interleukin-2 therapy in patients with HIV infection, , D Abrams, et al.
Circulation|June 21, 2008
State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summarySteven K Grinspoon, Carl Grunfeld, Donald P Kotler, et al.
Lancet (London, England)|August 22, 2015
The Vancouver Consensus: antiretroviral medicines, medical evidence, and political willChris Beyrer, Deborah L Birx, Linda-Gail Bekker, et al.
Trials|October 21, 2020
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis planPradeesh Sivapalan, Charlotte Suppli Ulrik, Therese Sophie Lappere, et al.
Annals of Internal Medicine|March 15, 2021
Risk for Non-AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy : A Multinational Prospective Cohort StudyFrédérique Chammartin, Sara Lodi, Roger Logan, et al.
HIV Medicine|October 7, 2017
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimensA Cozzi-Lepri, R Zangerle, L Machala, et al.
Plos One|January 24, 2013
Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study)Ann K Sullivan, Dorthe Raben, Joanne Reekie, et al.
Plos One|December 31, 2015
Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin AmericaAnne Marie W Efsen, Anna Schultze, Frank A Post, et al.
HIV Medicine|May 12, 2015
Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across EuropeM Mansfeld, A Skrahina, L Shepherd, et al.
The Lancet. HIV|March 5, 2016
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort studyDaria N Podlekareva, Anne Marie W Efsen, Anna Schultze, et al.
Pageof 69